监狱环境中对胺治疗的精神病学和法律考虑
Michael Bayrhammer-Savel1, Martin Ortner2, Marie-Claire Van Hout3
1Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
Frontiers in psychiatry
|May 3, 2024
概括
研究监狱中抑郁症和自杀倾向的胺治疗方法. 需要进一步的研究来平衡潜在的好处与滥用和未知的长期影响等风险.
科学领域:
- 心理健康 心理健康
- 精神病学是一个精神病学.
- 法律医学 法律医学
背景情况:
- 监狱中的公平医疗包括心理健康治疗.
- 监禁人员中抑郁症和自杀倾向的高率带来了治疗挑战.
- 传统抗抑郁药的有效性有限,需要先进的药理选择.
研究的目的:
- 介绍有关在惩戒设施中可获得胺治疗的观点.
- 讨论围绕监狱中胺使用的精神病学和法律考虑.
- 为了确定当前对这一群体的挑战和未来的研究需求.
主要方法:
- 审查当前的精神病学和法律文献.
- 关于获得药物的人权影响的分析.
- 讨论新的心理药理干预措施.
主要成果:
- 胺可以缓解监狱中的严重抑郁症状和自杀倾向.
- 拒绝有效药物可能违反人权标准.
- 潜在的问题包括关于长期影响和滥用风险的有限数据.
结论:
- 可访问的胺治疗可以改善对抑郁症的监禁个体的护理.
- 仔细考虑精神病学和法律因素对于实施至关重要.
- 进一步的研究对于建立监狱环境中的安全性和有效性至关重要.
更多相关视频
05:42Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
31.3K
07:07Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury
Published on: February 10, 2020
10.5K
相关概念视频
Psychosurgery
54
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
54
Parenteral Anesthetics: Overview
119
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
119
Psychosis: Goals of Pharmacotherapy
124
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
124
Electroconvulsive Therapy
37
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
37
Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
CNS Depressants: Barbiturates and Benzodiazepines
257
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
257
